Comparison of isatuximab-pomalidomide-dexamethasone versus elotuzumab-pomalidomide-dexamethasone in relapsed/refractory multiple myeloma patients: a target trial emulation using real-world data

Haematologica. 2025 Mar 6;110(8):1875-1881. doi: 10.3324/haematol.2025.287325.
No abstract available